Collaborative Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Collaborative Fund Advisors's VRTX Position: Q2 2026 in Review
Collaborative Fund Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2026, buying an estimated $47K and bringing the position to 1,036 shares worth $515K. The position accounts for 0.3% of the portfolio, ranked #96.
Collaborative Fund Advisors first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,741 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Collaborative Fund Advisors held 1,036 shares of Vertex Pharmaceuticals worth $515K as of Q2 2026.
- Collaborative Fund Advisors bought 106 Vertex Pharmaceuticals shares in Q2 2026, an estimated $47K.
- Vertex Pharmaceuticals made up 0.3% of Collaborative Fund Advisors's portfolio in Q2 2026, its #96 holding.
- Collaborative Fund Advisors first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,741 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Collaborative Fund Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.